v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash Flows From Operating Activities:    
Net loss $ (5,339,799) $ (2,223,255)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 51,781 42,713
Dividend and interest income (102,799) (151,596)
Stock-based compensation 2,009,126 2,028,374
Non-cash lease expense 36,062
Gain on exchange of warrants (1,711,698)
Change in fair value of warrant liabilities 634,119 137,319
Changes in operating assets and liabilities:    
Accounts receivable 163,400 (15,700)
Prepaid expenses and other current assets 5,830 (60,142)
Accounts payable 116,431 41,513
Accrued expenses and other current liabilities (466,875) (402,589)
Deferred revenue 150,000
Lease liability (38,781)
Net Cash Used In Operating Activities (2,778,786) (2,317,780)
Cash Flows From Investing Activities:    
Sale of marketable securities 3,456,535 5,800,000
Purchase of marketable securities (1,053,168) (10,728,006)
Purchases of equipment (36,400)
Net Cash Provided By (Used In) Investing Activities 2,366,967 (4,928,006)
Cash Flows From Financing Activities:    
Proceeds from issuance of common stock in at-the-market offering 1,083,915
Payment of issuance costs (33,608)
Exercise of stock options 42,411
Proceeds from exchange and issuance of warrants, net 7,528,027
Deferred offering costs (9,538)
Net Cash Provided By Financing Activities 1,092,718 7,518,489
Net Increase In Cash and Cash Equivalents 680,899 272,703
Cash and Cash Equivalents - Beginning of the Period 547,890 884,377
Cash and Cash Equivalents - End of the Period 1,228,789 1,157,080
Supplemental Disclosures of Cash Flow Information:    
Interest
Income taxes
Non-cash investing and financing activities:    
Accrued purchases of equipment 29,246
Return and cancellation of shares in lieu of payroll tax withholding 48,410
Issuance of common stock held in abeyance 6
Reclassification of deferred offering costs $ 148,697

Source